文献速递眼底病与葡萄膜炎

VEGFR1信号在视网膜血管生成与微炎症中的作用

VEGFR1 signaling in retinal angiogenesis and microinflammation.
PubMed 文献 · Prog Retin Eye Res · 2021-02-25

本文综述VEGFR1及其配体(VEGF-A、VEGF-B、PlGF)在视网膜血管生成、血管通透性和微炎症级联中的作用。VEGFR1表达受微环境调控,在缺氧和炎症条件下差异调节,表达于视网膜和脉络膜内皮细胞、周细胞、单核吞噬细胞、Müller细胞、光感受器细胞和视网膜色素上皮。VEGFR1除作为VEGF-A诱饵受体外,其直接信号可影响血管通透性并诱导巨噬细胞和小胶质细胞产生促炎和促血管生成介质。

要点

  • VEGFR1表达受微环境调控,缺氧和炎症条件下差异调节。
  • VEGFR1表达于视网膜和脉络膜多种细胞,包括内皮细胞、周细胞、单核吞噬细胞、Müller细胞、光感受器细胞和RPE。
  • VEGFR1直接信号可影响血管通透性并诱导巨噬细胞和小胶质细胞产生促炎和促血管生成介质。

核心结论

  • VEGFR1及其配体家族在视网膜血管生成、血管通透性和微炎症级联中具有重要作用。
  • VEGFR1的直接信号后果尚不明确,其配体间竞争受体结合和异二聚化使理解VEGFR1信号对病理过程的相对贡献变得复杂。

研究设计与样本

  • 综述性文章,检索范围未明确报告。

主要发现

  • VEGF-A结合VEGFR1和VEGFR2,而VEGF-B和PlGF仅结合VEGFR1。
  • VEGFR1表达于视网膜和脉络膜内皮细胞、周细胞、视网膜和脉络膜单核吞噬细胞(包括小胶质细胞)、Müller细胞、光感受器细胞和视网膜色素上皮。
  • VEGFR1激活可影响血管通透性并诱导巨噬细胞和小胶质细胞产生促炎和促血管生成介质。
  • VEGFR1配体(VEGF-A、PlGF和VEGF-B)间可竞争受体结合并形成异二聚体,使理解VEGFR1信号对糖尿病视网膜病变、视网膜血管阻塞、早产儿视网膜病变和年龄相关性黄斑变性的相对贡献复杂化。

临床怎么用

  • 抗VEGF药物在这些病理中已被证明具有变革性,其对VEGFR1信号调节的影响仍是进一步研究的热点领域。

局限性

  • VEGFR1直接信号的后果尚不明确。
  • VEGFR1配体间竞争受体结合和异二聚化使理解VEGFR1信号单独对病理过程的相对贡献复杂化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A, -B, -C, -D, and placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 and 2 (VEGFR1/2), whereas VEGF-B and PlGF only bind VEGFR1. Although much research has been conducted on VEGFR2 to elucidate its key role in retinal diseases, recent efforts have shown the importance and involvement of VEGFR1 and its family of ligands in angiogenesis, vascular permeability, and microinflammatory cascades within the retina. Expression of VEGFR1 depends on the microenvironment, is differentially regulated under hypoxic and inflammatory conditions, and it has been detected in retinal and choroidal endothelial cells, pericytes, retinal and choroidal mononuclear phagocytes (including microglia), Müller cells, photoreceptor cells, and the retinal pigment epithelium. Whilst the VEGF-A decoy function of VEGFR1 is well established, consequences of its direct signaling are less clear. VEGFR1 activation can affect vascular permeability and induce macrophage and microglia production of proinflammatory and proangiogenic mediators. However the ability of the VEGFR1 ligands (VEGF-A, PlGF, and VEGF-B) to compete against each other for receptor binding and to heterodimerize complicates our understanding of the relative contribution of VEGFR1 signaling alone toward the pathologic processes seen in diabetic retinopathy, retinal vascular occlusions, retinopathy of prematurity, and age-related macular degeneration. Clinically, anti-VEGF drugs have proven transformational in these pathologies and their impact on modulation of VEGFR1 signaling is still an opportunity-rich field for further research.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Uemura A, Fruttiger M, D'Amore PA, et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res. 2021. PMID: 33640465. doi:10.1016/j.preteyeres.2021.100954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。